Natco Pharma Ltd., the Indian drugmaker that had challenged Gilead Sciences Inc.’s patent claims on a blockbuster hepatitis C treatment in the Asian country, said it signed a licensing agreement with the US company for the drug.
Natco Pharma ties up with Gilead on hepatitis C drug
No comments:
Post a Comment